| Literature DB >> 28242209 |
Sari Lieberman1, Tom Walsh2, Menachem Schechter3, Tomer Adar3, Eran Goldin3, Rachel Beeri1, Nitzan Sharon4, Hagit Baris4, Liat Ben Avi5, Elizabeth Half6, Israela Lerer5, Brian H Shirts7, Colin C Pritchard7, Ian Tomlinson8, Mary-Claire King2, Ephrat Levy-Lahad9, Tamar Peretz10, Yael Goldberg11.
Abstract
Hereditary mixed polyposis syndrome is a rare colon cancer predisposition syndrome caused by a duplication of a noncoding sequence near the gremlin 1, DAN family BMP antagonist gene (GREM1) originally described in Ashkenazi Jews. Few families with GREM1 duplications have been described, so there are many questions about detection and management. We report 4 extended families with the duplication near GREM1 previously found in Ashkenazi Jews; 3 families were identified at cancer genetic clinics in Israel and 1 family was identified in a cohort of patients with familial colorectal cancer. Their clinical features include extracolonic tumors, onset of polyps in adolescence, and rapid progression of some polyps to advanced adenomas. One family met diagnostic criteria for Lynch syndrome. Expansion of the hereditary mixed polyposis syndrome phenotype can inform surveillance strategies for carriers of GREM1 duplications.Entities:
Keywords: CRC; Colon Cancer Susceptibility; HMPS1; Polyposis
Mesh:
Substances:
Year: 2017 PMID: 28242209 DOI: 10.1053/j.gastro.2017.02.014
Source DB: PubMed Journal: Gastroenterology ISSN: 0016-5085 Impact factor: 22.682